Since tumor progression is associated with increased tumor cell proliferation and yet autocrine TGF-β inhibited prostate cancer proliferation in vitro, we next examined how RER might affect tumor cell proliferation in vivo. Here, TGFB1 is linked to prostate carcinoma.